Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis
Authors:
- Şefik GüranŞGŞefik Güran
- Ahmet ÖzetAÖAhmet Özet
- Murat DedeMDMurat Dede
- Johan J.P. GilleJGJohan J.P. Gille
- Müfit Cemal YenenMYMüfit Cemal Yenen
- 15 July 2005
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 160 (2) , 164-168
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prenatal diagnosis history of a Li-Fraumeni syndrome familyCancer Genetics and Cytogenetics, 2005
- A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancerCancer Genetics and Cytogenetics, 2005
- Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approachBritish Journal of Cancer, 2002
- Molecular Pathologic Analysis Enhances the Diagnosis and Management of Muir-Torre Syndrome and Gives Insight Into Its Underlying Molecular PathogenesisAmerican Journal of Surgical Pathology, 2001
- Hereditary TP53 Codon 292 and Somatic P16INK4A Codon 94 Mutations in a Li-Fraumeni Syndrome FamilyCancer Genetics and Cytogenetics, 1999
- p53 and p16INK4A Mutations during the progression of glomus tumorPathology and Oncology Research, 1999
- Loss of The Normal NF1 Allele from the Bone Marrow of Children with Type 1 Neurofibromatosis and Malignant Myeloid DisordersNew England Journal of Medicine, 1994
- A variation in the structure of the protein-coding region of the human p53 geneGene, 1988
- PRACTICAL GUIDE FOR ESTIMATING RISK FOR FAMILIAL BREAST CANCERThe Lancet, 1983
- Genetic study of breast cancer: Identification of a high risk groupCancer, 1974